More on NXTS

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nexentis Technologies (NQ:NXTS)
Delayed: 5.08 -0.26 (4.87%)
Prev. Close $5.34  
Open$4.97 
52 Wk High$ 
52 Wk Low$ 
Day High$5.58 
Day Low$4.97 
P/E N/A  
EPS$ 
Volume90,232 


Jun 17, 2026 07:33 AM MitoCareX Bio completes SLC transport protein structural analysis
Jun 17, 2026 07:32 AM Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
Jun 15, 2026 06:16 AM Form 424B5 Nexentis Technologies
Jun 12, 2026 04:16 PM Form 8-K Nexentis Technologies For: Jun 12
May 27, 2026 04:07 PM Form 8-K Nexentis Technologies For: May 27
May 18, 2026 09:34 AM Nexentis unit achieves drug discovery milestone with improved molecule
May 18, 2026 09:31 AM Nexentis subsidiary hits drug discovery milestone for cancer treatment
May 18, 2026 09:30 AM Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
May 18, 2026 09:30 AM Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
May 13, 2026 07:07 AM Nexentis subsidiary achieves drug discovery milestone
View All Articles

Entities mentioned with NXTS

View All Entities